Mr Senthil Lingaratnam
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
42 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial
DOI: 10.1093/cid/ciaf4092026
Journal article
Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients
DOI: 10.1177/107815522614459562025
Journal article
An Australasian survey of clinical practices in management of neutropenic fever in adult cancer patients 2023
DOI: 10.1111/imj.702732025
Journal article
Usability testing of an online, evidence-based pharmacogenomics education program for pharmacists working in cancer care
DOI: 10.1016/j.cptl.2025.1024782025
Journal article
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
DOI: 10.1007/s40261-025-01489-w2025
Research grants (ARC, NHMRC, MRFF)
Trial Implementation of Pharmacogenomics to Improve Complex Hospital Care
2025
Journal article
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
DOI: 10.1111/cts.70144
RECENT SCHOLARLY WORKS
2024
Journal article
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial
DOI: 10.1111/cts.700832024
Journal article
Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer
DOI: 10.1016/j.cllc.2024.04.0012024
Journal article
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
DOI: 10.1177/107815522311808752024
Journal article
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer
DOI: 10.1111/cts.13781